Targeted Muscle Reinnervation Study (TMR) - Trial NCT05408520
Access comprehensive clinical trial information for NCT05408520 through Pure Global AI's free database. This phase not specified trial is sponsored by Joshua Hustedt and is currently Recruiting. The study focuses on Amputation. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Joshua Hustedt
University of Arizona
Timeline & Enrollment
N/A
Dec 01, 2022
May 01, 2025
Primary Outcome
Effect of TMR on neuroma,Effect of TMR on phantom limb pain
Summary
The purpose of this study is to examine the effect of targeted muscle reinnervation on the
 outcomes of amputees at a level 1 trauma center. The investigators propose to randomize all
 patients requiring amputation with and without targeted muscle reinnervation. This study will
 help delineate the efficacy of targeted muscle reinnervation in the general population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05408520
Non-Device Trial